402 related articles for article (PubMed ID: 27813081)
21. Evaluation of molecular analysis in challenging ovarian sex cord-stromal tumours: a review of 50 cases.
Stewart CJR; Amanuel B; De Kock L; Apellaniz-Ruiz M; Carrello A; Giardina T; Grieu-Iacopetta F; Thomas MA; Foulkes WD
Pathology; 2020 Oct; 52(6):686-693. PubMed ID: 32782216
[TBL] [Abstract][Full Text] [Related]
22. Update on Ovarian Sex Cord-Stromal Tumors.
Ordulu Z
Clin Lab Med; 2023 Jun; 43(2):245-274. PubMed ID: 37169445
[TBL] [Abstract][Full Text] [Related]
23. Update on Ovarian Sex Cord-Stromal Tumors.
Ordulu Z
Surg Pathol Clin; 2022 Jun; 15(2):235-258. PubMed ID: 35715160
[TBL] [Abstract][Full Text] [Related]
24. Lessons from genomic profiling: towards a molecular-based classification of ovarian Sertoli-Leydig cell tumour.
Kommoss FKF
Histopathology; 2024 Mar; 84(4):712-714. PubMed ID: 38114269
[TBL] [Abstract][Full Text] [Related]
25. DICER1 -Altered Extraovarian Moderately Differentiated Sertoli-Leydig Cell Tumor: Report of a Rare Case.
Lau JCC; McCluggage WG; Yuen LYP; Shing MMK; Chan GCF; Yam FSD; Leung MWY; Ng WF; Liu APY
Int J Gynecol Pathol; 2023 Jul; 42(4):421-425. PubMed ID: 36044308
[TBL] [Abstract][Full Text] [Related]
26. Rare DICER1 and Absent FOXL2 Mutations Characterize Ovarian Juvenile Granulosa Cell Tumors.
Baillard P; Genestie C; Croce S; Descotes F; Rouleau E; Treilleux I; Gouy S; Morice P; Ray-Coquard I; McCluggage WG; Devouassoux-Shisheboran M
Am J Surg Pathol; 2021 Feb; 45(2):223-229. PubMed ID: 32910017
[TBL] [Abstract][Full Text] [Related]
27. [Sex cord-stromal tumors of the ovary : Current aspects with a focus on granulosa cell tumors, Sertoli-Leydig cell tumors, and gynandroblastomas].
Kommoss F; Lehr HA
Pathologe; 2019 Feb; 40(1):61-72. PubMed ID: 30659330
[TBL] [Abstract][Full Text] [Related]
28. Well-differentiated Sertoli-Leydig Cell Tumors (SLCTs) Are Not Associated With DICER1 Pathogenic Variants and Represent a Different Tumor Type to Moderately and Poorly Differentiated SLCTs.
McCluggage WG; Rivera B; Chong AS; Clarke BA; Schultz KAP; Dehner LP; Tchrakian N; Apellaniz-Ruiz M; Gilks CB; Kommoss F; Stewart CJR; Foulkes WD
Am J Surg Pathol; 2023 Apr; 47(4):490-496. PubMed ID: 36583307
[TBL] [Abstract][Full Text] [Related]
29. Review on Sertoli-Leydig Cell Tumours of the Ovary.
Muscat C; Calleja-Agius J
Discov Med; 2024 Feb; 36(181):234-247. PubMed ID: 38409829
[TBL] [Abstract][Full Text] [Related]
30. Ovarian sex cord-stromal tumours: an update in recent molecular advances.
Lim D; Oliva E
Pathology; 2018 Feb; 50(2):178-189. PubMed ID: 29275930
[TBL] [Abstract][Full Text] [Related]
31. DICER1 Mutation in Recurrent Ovarian Sertoli-Leydig Cell Tumor: A Case Report.
Liu S; Pokoradi AJ; Soboleski D; Childs T; Agrawal A
J Pediatr Adolesc Gynecol; 2023 Apr; 36(2):107-111. PubMed ID: 36402443
[TBL] [Abstract][Full Text] [Related]
32. Detection of FOXL2 C134W Mutation Status by a Novel BaseScope In Situ Hybridization Assay is Highly Sensitive and Specific for Adult Granulosa Cell Tumors.
Hammer PM; Wang A; Beard C; Zdravkovic S; Tenney T; Liang B; Das I; Bremer R; Wang LC; McCluggage WG; Stewart CJR; Howitt BE
Mod Pathol; 2023 Nov; 36(11):100318. PubMed ID: 37634867
[TBL] [Abstract][Full Text] [Related]
33. [The pathology of hereditary ovarian tumors].
Pesce F; Devouassoux-Shisheboran M
Ann Pathol; 2020 Apr; 40(2):85-94. PubMed ID: 32178889
[TBL] [Abstract][Full Text] [Related]
34. Mutation of FOXL2 in granulosa-cell tumors of the ovary.
Shah SP; Köbel M; Senz J; Morin RD; Clarke BA; Wiegand KC; Leung G; Zayed A; Mehl E; Kalloger SE; Sun M; Giuliany R; Yorida E; Jones S; Varhol R; Swenerton KD; Miller D; Clement PB; Crane C; Madore J; Provencher D; Leung P; DeFazio A; Khattra J; Turashvili G; Zhao Y; Zeng T; Glover JN; Vanderhyden B; Zhao C; Parkinson CA; Jimenez-Linan M; Bowtell DD; Mes-Masson AM; Brenton JD; Aparicio SA; Boyd N; Hirst M; Gilks CB; Marra M; Huntsman DG
N Engl J Med; 2009 Jun; 360(26):2719-29. PubMed ID: 19516027
[TBL] [Abstract][Full Text] [Related]
35. [Ovarian Sertoli-Leydig cell tumors: DICER1 hotspot mutations and associated clinicopathological features].
Xiao YX; Zhu XL; Bi R; Tu XY; Cheng YF; Chang B; Yu L; Huang D; Lu YM; Shan L; Yang WT
Zhonghua Bing Li Xue Za Zhi; 2020 May; 49(5):441-447. PubMed ID: 32392927
[No Abstract] [Full Text] [Related]
36. Impact of FOXL2 mutations on signaling in ovarian granulosa cell tumors.
Leung DTH; Fuller PJ; Chu S
Int J Biochem Cell Biol; 2016 Mar; 72():51-54. PubMed ID: 26791928
[TBL] [Abstract][Full Text] [Related]
37. The FOXL2 mutation (c.402C>G) in adult-type ovarian granulosa cell tumors of three Japanese patients: clinical report and review of the literature.
Takahashi A; Kimura F; Yamanaka A; Takebayashi A; Kita N; Takahashi K; Murakami T
Tohoku J Exp Med; 2013 Dec; 231(4):243-50. PubMed ID: 24257635
[TBL] [Abstract][Full Text] [Related]
38. Sex Cord Tumor With Annular Tubules-Like Histologic Pattern in Adult Granulosa Cell Tumor: Case Report of a Hitherto Unreported Morphologic Variant.
Chang RJ; Reuther J; Gandhi I; Roy A; Jain S; Masand RP
Int J Surg Pathol; 2021 Jun; 29(4):433-437. PubMed ID: 32856501
[TBL] [Abstract][Full Text] [Related]
39. DICER1 Mutations Are Consistently Present in Moderately and Poorly Differentiated Sertoli-Leydig Cell Tumors.
de Kock L; Terzic T; McCluggage WG; Stewart CJR; Shaw P; Foulkes WD; Clarke BA
Am J Surg Pathol; 2017 Sep; 41(9):1178-1187. PubMed ID: 28654427
[TBL] [Abstract][Full Text] [Related]
40. Adult-type granulosa cell tumor of the ovary: a FOXL2-centric disease.
Pilsworth JA; Cochrane DR; Neilson SJ; Moussavi BH; Lai D; Munzur AD; Senz J; Wang YK; Zareian S; Bashashati A; Wong A; Keul J; Staebler A; van Meurs HS; Horlings HM; Kommoss S; Kommoss F; Oliva E; Färkkilä AE; Gilks B; Huntsman DG
J Pathol Clin Res; 2021 May; 7(3):243-252. PubMed ID: 33428330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
